Hims & Hers Health HIMS Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction

Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction at other companies

EFC

Ellington Financial Inc.EFC

-$2.32M—

TG TherapeuticsTGTX

$0—

American Homes 4 RentAMH

$5.03M+406%

GlobalstarGSAT

$620.5K—

Tractor Supply CompanyTSCO

$0—

TPG RE Finance Trust, Inc.TRTX

——

Other financials

Income statement

See full

Revenue$608.1M+3.8%

Gross profit$396.8M-7.9%

Operating income-$78.3M-235%

Net income-$92.1M-286%

EPS (diluted)-$0.40-300%

Balance sheet

See full

Cash & equivalents$222.3M-19.2%

Total debt$157.9M+149%

Total equity$446.2M-18.8%

Total assets$2.3B+154%

Cash flow

See full

Operating cash flow$89.4M-18.1%

CapEx$8.8M-19.9%

Free cash flow$80.5M-17.9%

Valuation

See full

Market cap$8.21B-27.9%

Enterprise value$8.15B-26.5%

P/S3.5×-2.9×

Profitability

See full

Gross margin71.7%-5.3pp

Operating margin-1.3%-7.5pp

Net margin-0.6%-9.8pp

FCF margin11.9%-5.8pp

Returns & leverage

See full

Return on equity-2.7%-39.4pp

Debt / equity0.4×+0.2×

Current ratio1.7×+0.1×

Where this comes from

Reported directly by Hims & Hers Health in its filing.

Tagged under the XBRL concept us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction.

The official record: Hims & Hers Health’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Hims & Hers Health's debt issuance costs incurred during noncash or partial noncash transaction.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Hims & Hers Health's debt issuance costs incurred during noncash or partial noncash transaction?: Hims & Hers Health (HIMS) reported debt issuance costs incurred during noncash or partial noncash transaction of $0 in Q1 2026.